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Outcome and growth of infants with severe chronic renal failure. maintain an adequate energy intake in the child with
Background. We aimed to assess the outcome and growth CRF, who is often difficult to feed and frequently vomits.
of infants with severe chronic renal failure (CRF). One hundred Furthermore, many infants have structural renal abnor-and one children presented between January 1, 1986, and De-
malities and may need multiple operations with the asso-cember 12, 1998, with a glomerular filtration rate (GFR) of
ciated accompanying periods of fasting. In our unit, we,20 mL/min/1.73 m2. The median (range) age at presentation
was 0.3 (0 to 1.5) years, and follow-up was 7.6 (1.5 to 13) years. aim to optimize growth by the commencement of enteral
One- and five-year survival rates were 87 and 78%, respectively. feeding as soon as there is subnormal growth. In this
The growth of the 81 children who survived over two years article, we report the outcome of all the children withwas evaluated. Eighty-one percent were enterally fed from age
severe CRF who presented over the last 13 years to our0.7 (0 to 4.5) years for 1.9 (0.1 to 6.8) years. Forty-six percent
unit at less than 2 years of age. We also report the effecthad a gastrostomy, and 22% a Nissen fundoplication. Twenty-
five were managed conservatively. Twenty were transplanted of our enteral feeding policy on their growth. Our results
without dialysis at age 4 (1.7 to 8.5) years, and 36 were dialyzed show that, although the mortality of infants with severe
at age 1.1 (0 to 9.8) before transplantation at age 2.4 (1.3 to comorbid conditions is high, those whose only disease10) years.
is CRF have a survival similar to older children. We haveResults. The mean (SD) height standard deviation score in-
also shown that good growth can be attained withoutcreased from 22.16 (1.34) at 6 months (N 5 63) to 21.97 (1.37)
at 1 year (N 5 75), 21.79 (1.29) at 2 years (N 5 75), 21.33 the use of recombinant human growth hormone (rhGH).
(1.29) at 3 years (N 5 68, P 5 0.0006), 21.27 (1.04) at 5 years
(N 5 47, P 5 0.0001), and 20.85 (0.82) at 10 years (N 5 18,
P 5 0.001). The body mass index was in the normal range in METHODS
the majority of patients.
Entry criteriaConclusion. Mortality in infants with CRF occurs mainly in
the first year of life. With early enteral feeding, the mean height All children who were born after January 1, 1986, and
standard deviation score is within the normal range from one were at least one year old by December, 12, 1998, who
year of age. attended Gt. Ormond St. Children’s Hospital renal unit
and who had CRF presenting in the first six months of
life with a glomerular filtration rate (GFR) of ,20 mL/
The acceptance of infants onto end-stage renal failure min/1.73 m2 (measured by clearance of 51Cr-EDTA) be-
(ESRF) programs has become increasingly common over tween one and two years or who were dialyzed or trans-
the last 15 years [1]. However, the mortality and morbid- planted within the first two years of life were included
ity of these young patients remain unknown. It might be in the study.
expected that growth would be a particular problem, as
it has been recognized for many years that chronic renal Management policy
failure (CRF) presenting in the first two years of life The children were reviewed frequently (on average,
may have a long-standing adverse effect on height [2]. monthly) by a senior doctor and renal dietitian. The
This is because growth in infancy is predominantly de- plasma phosphate was kept below the 50th percentile
pendent on nutrition, and it is notoriously difficult to for age using calcium carbonate, and the calcium was
kept at the upper limit of the normal range using the
lowest possible dose of activated vitamin D in order toKey words: enteral feeding, gastrostomy, Nissen fundoplication, dial-
ysis, transplantation, parathyroid hormone. try to maintain the serum parathyroid (PTH) within the
normal range. Strict attention was also paid to main-Received for publication May 4, 1999
taining the acid-base balance and hemoglobin within theand in revised form October 27, 1999
Accepted for publication November 1, 1999 normal range. Erythropoietin was prescribed at a starting
dose of 100 units per kg subcutaneously per week whenÓ 2000 by the International Society of Nephrology
1681
Kari et al: CRF in infancy1682
the hemoglobin fell below 9.5 g/dL. Salt supplements presented as the percentage within the normal range
because of assay changes during the time period.were used in the majority of children.
Any child with a declining growth velocity was offered
Statistical analysisenteral feeding, first by nasogastric tube, converting to
Regression analysis was used to see whether surgicala percutaneous endoscopic gastrostomy in those with
procedures influenced growth, and Cox regression analy-conservatively managed CRF, but an open gastrostomy
sis was used for patient survival. Paired t-tests and analy-in children on dialysis. The aim of the enteral feed was
sis of variance (ANOVA) were used to compare theto provide 100% of the estimated average requirement
height standard deviation score (Ht SDS) from the samefor energy for chronological age, and at least 100% of
children at different time points. Results are given asthe reference nutrient intake for protein for height age
mean (SD) or median (range). A P value of ,0.05 was[3]. Height age was used for protein intake and chrono-
considered significant.logical age for energy in order to ensure adequacy of
protein intake without an excess nonprotein energy in-
take. A whey-dominant infant formula was used in those RESULTS
under two years of age, and a whole-protein enteral feed,
A total of 101 children (73 male) fulfilled the criteria.
supplemented with fat or carbohydrate or both, was used
Twenty-six were preterm (,37 weeks gestation). The
for children who were more than two years. At each median (range) gestational age was 37 (30 to 44) weeks.
outpatient visit, energy and protein intakes were assessed Eighteen were of low birthweight, and 10 were both
by the dietitian. If targets were not met, the dietary preterm and of low birthweight. The median (range) age
prescription was adjusted accordingly. In those under at presentation to our unit was 0.3 (birth to 1.5) years,
one year of age, approximately one half of the feed was and follow-up was 7.6 (1.5 to 13) years. Twenty-nine
administered as boluses during the day, and one half patients were diagnosed antenatally. Diagnoses were:
was administered as a continuous overnight feed. The dysplasia (N 5 55), posterior urethral valve (PUV) (25),
proportion delivered overnight was increased thereafter congenital nephrotic syndrome (11), cortical necrosis (7),
in order to improve the appetite during the day. If there tubulointerstitial disease (2), and bilateral Wilms’ tumor
was vomiting, the feeds were manipulated to give either (1). Comorbid conditions were: developmental delay (14),
small, frequent volumes or continuous feeds, and proki- blindness and deafness (2), congenital heart disease (7),
netic drugs were added. A Nissen fundoplication was cystic fibrosis (1), gut resection and ileostomy (2), ulcera-
used if vomiting persisted. The parents were taught how tive colitis (1), hypothyroidism (2), respiratory disease
to administer the feeds and took full responsibility at (2), CHARGE and VATER association (2), and other
home, with community support if necessary. syndromes such as Down (1), Jeune (2), Alagille (1).
At ESRF, most children were dialyzed peritoneally;
hemodialysis was used if peritoneal dialysis failed. The Deaths
children were placed on the transplant waiting list when Patient survival is shown in Figure 1. There were 23
they reached the weight of 8 kg. rhGH was offered to deaths, of whom 13 died following treatment withdrawal.
children with a declining growth velocity despite enteral Thirteen deaths were in the first year. Of these, 10 chil-
feeding. dren had their treatment withdrawn: Three parents chose
no further intervention in otherwise normal infants. Four
Data collection were severely developmentally delayed. One had had a
The following information was obtained from the pa- gut resection. One had pulmonary hypoplasia, and one
tient records: the presence of an antenatal diagnosis, had cystic fibrosis. The other three children died of un-
birthweight and gestation, diagnoses, comorbid condi- known causes, two of whom were peritoneally dialyzed
tions, causes of death, number of surgical interventions and had severe developmental delay. Five children died
in the first two years of life, first available length (mea- between one and two years of age. Of these, four, who
sured by stadiometer, lying until 2 years and standing if were peritoneally dialyzed, were severely developmen-
possible thereafter) and weight, with serum creatinine tally delayed, and two were also blind. Causes of death
and PTH level [a C-terminal assay was used until April were treatment withdrawal, sepsis, and mesenteric in-
1989 (range 220 to 660 ng/L) and intact PTH thereafter farct and pulmonary edema. The fifth child, who was
(range, 5 to 45 ng/L until 1994, 1 to 6.5 pmol/L until otherwise normal, died of an unknown cause. Two chil-
1997, 1 to 5.4 pmol/L thereafter], length, weight, serum dren died between the ages of two and three years: one
creatinine, and PTH every six months and at change of had treatment withdrawn (Jeune’s syndrome), and one,
treatment modality (but PTH was not analyzed after who was otherwise normal, died on peritoneal dialysis
transplant), date of onset, and the duration of enteral of hyperkalemia. Thereafter, one child died at 3.1 years
of a gastrointestinal hemorrhage post-transplant. Onefeeding or rhGH therapy. The PTH values have been
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Fig. 1. Patient survival.
died at 5.3 years following treatment withdrawal for se- creatinine (mmol/L) was 173 (87) at one year and 306 (179)
at five years of age, and GFR (by 51Cr-EDTA) betweenvere developmental delay, and one died on hemodialysis
at 8.3 years of age. one and two years was 12.5 (4.1) mL/min/1.73 m2. Eighty
percent of PTH values were within the normal range.The data of the 20 who died in the first 2.3 years of
life were not included in the rest of the analyses because Twenty (80%) were enterally fed; 17 (68%) had a gas-
trostomy, and six (24%) had a Nissen fundoplication.17 had less than 1 year of follow-up, two were not seen
regularly because of treatment withdrawal, and the oth- The median (range, years) age at the start of enteral
feeding was 0.7 (birth to 2), and the duration was 2.7er’s data were missing. The remaining 81 children were
(0.9 to 6.1). One child was given rhGH as part of a trialdivided into three groups: group 1 (N 5 25) was managed
at age 0.9 years for 1.8 years, and one with a possibleconservatively throughout; group 2 (N 5 20) was man-
skeletal dysplasia at 1.8 years for a duration of 1.6 years.aged conservatively until transplantation; and group 3
The Ht SDS values at six monthly intervals are shown(N 5 36) was dialyzed until transplantation.
in Figure 2. The mean (SD) Ht SDS showed a steady
Surgery improvement with age, increasing from 22.34 (1.27) at
six months (N 5 24) to 22.26 (1.27) at one year (N 5The median number of surgical interventions for all
25), 21.93 (1.16) at two years (N 5 24), and 21.37 (0.72)the children in the first year of life was two (range 0 to
at five years (N 5 10). The improvement in Ht SDS over8). These included cystoscopy, resection of the posterior
the first two years did not reach significance (P 5 0.59),urethral valve (PUV), and urinary drainage procedures
but by three years it was significant (P 5 0.037) and(for example, nephrostomy, suprapubic catheter, ureter-
continued to improve thereafter (P 5 0.003 at 5 years).ostomy). There was no correlation between the number
Mean body mass index (BMI) was within the normalof surgical interventions and Ht SDS at the age of one
range at all ages: 15.48 (1.67) at six months of age (2nd(P 5 0.35) or two years (P 5 0.77).
percentile), 15.93 (1.72) at one year (9th percentile),
Enteral feeding 15.88 (1.68) at two years (25th percentile), and 16.00
(1.62) at five years (50th percentile).Overall, sixty-six (81%) of the patients were enterally
fed from a median age of 0.7 (range 0 to 4.5 years) and
Group 2duration of 1.9 (0.1 to 6.8) years. Thirty-seven (46%) had
The median (range, years) age at presentation fora gastrostomy, and 18 (22%) also had a Nissen fundopli-
group 2 patients (N 5 20) was 0.3 (0.1 to 1.1). At trans-cation. Enteral feeding had stopped by six months post-
plant, the median was 4.0 (1.7 to 8.5), and the durationtransplant in all but two children (one with CHARGE
of follow-up was 10.4 (3.2 to 13). Three children receivedsyndrome and one with severe developmental delay).
live related transplants. Two children’s transplants failed
Group 1 at 3.9 and 4.4 years of age, having never functioned.
They were re-transplanted at 5.8 and 5.1 years, respec-For group 1 patients (N 5 25), the median (range,
years) age at presentation was 0.2 (0.1 to 0.7), and the tively. The latter child’s second transplant failed, and he
received a third transplant at 6.9 years of age. The meanduration of follow-up was 6.4 (1.5 to 12.6). The mean (SD)
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Fig. 2. Height standard deviation score (Ht
SDS) at the age of six months and six monthly
intervals thereafter in the conservatively man-
aged patients (group 1).
Fig. 3. Ht SDS at the age of six months and at
six monthly intervals thereafter in the children
who were conservatively managed until trans-
plantation (group 2). Values before transplant
are shown by solid lines, post-transplant by
the dotted lines, those on dialysis by gray lines,
and failed transplants are shown by diamond
symbols.
(SD) creatinine was 254 (108) mmol/L at one year of at six months (N 5 13), 21.98 (1.15) at one year (N 5 18),
22.00 (1.16) at two years (N 5 19), and then improvedage. Sixty percent of PTH values before transplantation
were within the normal range. Fourteen (70%) were steadily to 21.58 (1.17) at five years (N 5 10). However,
this improvement did not reach significance (P 5 0.87).enterally fed. Four (20%) had a gastrostomy, and two
(10%) had a Nissen fundoplication. The median (range, The Ht SDS at transplantation was 21.71 (0.81, N 5
20), 21.14 (0.90) after one year (N 5 20), 20.61 (0.74)years) age at the start of enteral feeding was 1.1 (0.1 to
4.7), and the duration was 1.9 (0.4 to 5.6). Two children after two years (N 5 13), and 20.55 (0.97) at five years
(N 5 9). The improvement in Ht SDS after the firstwere given rhGH at ages 4 and 5.2 years for 2.0 and 1.7
years, respectively. The mean BMI pretransplant was year of transplantation was significant (P 5 0.0002) and
continued to improve thereafter (P # 0.001 each yearwithin the normal range at all ages: 16.36 (2.15) at six
months (9th percentile), 16.59 (2.15) at one year (9th from 2 to 5 years).
percentile), 17.52 (2.34) at two years (75th percentile).
Group 317.59 (2.30) at five years (75th percentile), and 19.02
(2.50) at seven years (91st percentile). In group 3 patients (N 5 36) the median (range, years)
age at presentation was 0.5 (0.1 to 2.0), and at the startThe Ht SDS values at six monthly intervals before
and after transplantation are shown in Figure 3. Before of dialysis, the median was 1.1 (0.1 to 9.8). Thirty-four
(94%) were transplanted at 2.5 (1.3 to 10.0) years of age.transplantation, the mean (SD) Ht SDS was 21.72 (1.50)
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Four transplants were live related. Six grafts were lost DISCUSSION
within 10 days, and a further three at a mean (range) of This study demonstrates two important conclusions:
6.7 (4.1 to 11.7) years of age. Five patients received second First, the mortality for infants without comorbid condi-
transplants at five (2.7 to 8.4) years, and two of these were tions with severe CRF is similar to the rate in older
lost. The duration of follow-up was 6.8 (2 to 13) years. children, and second, intensive medical management and
Sixty-two percent of PTH values before transplantation enteral feeding can allow catch-up growth even in infants
were within the normal range. Thirty-two (89%) were and young children presenting with severe CRF.
enterally fed; 16 (44%) had a gastrostomy and 8 (22%) The European Dialysis and Transplant Association
a Nissen fundoplication. The median (range, years) age (EDTA) reported one-year survival of children aged two
at start of enteral feeding was 0.5 (0.1 to 3.4), and the to five years to be approximately 90% after one year
and 83% after three years of renal replacement therapyduration was 2.0 (0.1 to 6.8). One child was given rhGH
[1]. Over half of the 23 deaths in our study were due toat the age of 10.9 for 1.7 years. The mean BMI pretrans-
withdrawal of treatment because of parental choice orplant was within the normal range at all ages: 16.50 (2.10)
severe comorbid conditions, so that the survival duringat six months (25th percentile), 17.68 (2.38) at one year
the follow-up period of those accepted for ESRF man-(50th percentile), 17.53 (4.60) at two years (75th percen-
agement was 90%. Only five of the children who diedtile), 16.95 (2.52) at five years (75th percentile), and 18.07
after acceptance onto the ESRF program did not have(1.03) at seven years (91st percentile).
severe comorbid conditions. Although the mortality ofThe Ht SDS values at six monthly intervals are shown
our patients on peritoneal dialysis was higher than inin Figure 4. Figure 4A shows the 13 infants dialyzed
the 21 infants reported by Ellis et al [4], our resultsbefore six months of age [median (range) age, years 0.1
substantiate their conclusion that infants with comorbid(0.1 to 0.4)]. Their mean (SD) Ht SDS was 22.17 (1.56)
conditions have the highest mortality.at six months (N 5 13), 22.09 (1.25) at one year (N 5
Unlike most studies, we have shown that strict atten-13), 21.24 (1.52) at two years (N 5 9), and 20.25 (1.17)
tion to the provision of an adequate energy intake inat 2.5 years (N 5 5). The improvement in Ht SDS did
infancy and early childhood can lead to catch-up growth.not reach significance (P 5 0.09). Figure 4B shows the
Although we have not calculated the energy and protein23 dialyzed after six months of age [1.4 (0.8 to 9.8) years].
intake in all of the children in this study, previous analysisThe mean (SD) Ht SDS during conservative manage-
from our unit has shown that the nonprotein energy fromment was 22.28 (1.51) at six months (N 5 14), 22.35
such a feeding regimen is between 100 and 150 calories(1.26) at one year (N 5 15), 21.79 (1.31) at two years
per 100 mL, that between 52 and 82% of energy is from(N 5 13), and 21.02 (1.15) at three years (N 5 5). The
the feed, and that the achieved percentage of the recom-Ht SDS was 21.64 (1.73) at the start of dialysis (N 5
mended intake for protein is 110 to 173% and for energy23), 21.83 (1.28) after six months (N 5 21), 21.56 (1.33)
is 86 to 104% [5]. Other studies using tube feeding atafter one year (N 5 13), 21.48 (1.14), after 1.5 years
this age have had variable results. Some have shown that
(N 5 10), and 21.0 (1.47) after two years (N 5 7). The
dramatic catch-up growth can occur in some, but not all
improvement in Ht SDS was not significant both during infants [6], and results from our own unit in a group of
conservative management (P 5 0.20) and dialysis (P 5 infants and young children enterally fed for over a year
0.76). Ht SDS at transplantation in those whose grafts have also demonstrated catch-up [5]. Others have shown
did not fail in the first 10 days was 21.54 (1.38; N 5 30), that normal growth, but not catch-up, can occur [7, 8].
20.99 (1.32) after one year (N 5 28), 20.97 (1.25) after The biggest study of the growth of infants with CRF
two years (N 5 20), and 21.28 (0.92) at five years (N 5 is that of the European Study group for nutritional treat-
10). The improvement in Ht SDS post-transplant was ment of CRF in childhood [9]. This included 73 infants
significant after one year (P , 0.0001). However, it was between 1970 and 1992 who presented before six months
insignificant thereafter (P 5 0.19 after 2 years and P 5 of age, and who had a GFR of ,50 mL/min/1.73 m2 at
0.53 after 5 years). the age of one year or later. The study identified that
already one standard deviation of height had been lost
Growth of all children during fetal life, and that by three months of age, a
Figure 5 shows the growth of all of the children at all further standard deviation had been lost. This is the time
times. The mean Ht SDS was within the normal range when growth is predominantly dependent on nutrition.
by one year of age and continued to improve thereafter. From three to nine months, there was little change in
The improvement in Ht SDS over the first two years did height, but thereafter, there was a further decline until 1.5
not reach significance (P 5 0.55), but by three years, it years, when the mean (SD) Ht SDS was 23.03 (1.48). The
was significant (P 5 0.0006) and continued to improve authors postulated that this represented a change to the
phase of growth that is growth hormone (GH) depen-thereafter (P # 0.001 each year from 4 to 12 years).
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Fig. 4. (A) Ht SDS at the age of 6 months
and at six monthly intervals thereafter in the
children who were dialyzed (before 6 months
of age) before transplantation (group 3). Val-
ues before transplant are shown by solid lines,
post-transplant by dotted lines, on return to
dialysis by gray lines, and failed transplants
are shown by the diamond symbols. (B) Ht
SDS at the age of six months and at six
monthly intervals thereafter in the children
who were dialyzed (after 6 months of age)
before transplantation (group 3). Values be-
fore transplant on conservative management
are shown by dashed lines, on dialysis by solid
lines, post-transplant by dotted lines, on re-
turn to dialysis by gray lines; failed transplants
are shown by the diamond symbols, and
deaths by solid boxes.
Fig. 5. Mean (SD) Ht SDS at six monthly
intervals for all the children at all ages. The
number of children at each time point is shown
by the number inside each bar.
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dent, and the resistance to GH, with its negative effect in the treated group, whereas there was no change from
22.5 (0.9) at baseline to 22.7 (1.2) at two years in theon growth, takes effect. Between 1.5 and 5 years of age,
there was little change in growth rate, so the Ht SDS at controls. The results of the use of rhGH are similar
to our results, although the patients groups differ: Ourfive years of age was 22.82 (1.63). There was no correla-
tion between GFR and growth in this analysis. However, patients were less growth retarded, but their mean GFR
was worse. We recommend the use of rhGH in thesethere was a correlation between height at one year of age
and serum albumin, which is recognized to be an indicator young children when growth retardation persists despite
adequate nutritional support, and it is imperative thatof adequate nutrition. The North American Pediatric
Renal Transplant Co-operative Study (NAPRTCS) has nutritional support should be continued during rhGH
therapy.also reported on the growth of young patients with con-
servatively managed CRF [10]. Fifty percent of children In conclusion, the prognosis over the first decade of
life for the infant presenting with severe CRF is good.below the age of five years with a GFR of ,75 mL/min/
1.73 m2 had a Ht SDS below the normal range. It is not Survival in otherwise healthy infants is similar to older
children, and normal growth can occur if strict attentionstated how many children were enterally fed in either
of these studies. is paid to maintaining an adequate energy intake.
Although the study groups in the European and the
Reprint requests to Lesley Rees, M.D., Renal Office, Gt. Ormond
NAPRTCS data are different than ours, as one is a St. Hospital for Children NHS Trust, Gt. Ormond Street, London WC1N
3JH, England, United Kingdom.multicenter and covers an earlier time period [9] and
E-mail: L.Rees@ich.ucl.ac.ukthe other is a registry [10], it is likely that the better
growth seen in our patients is due to the provision of an
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